| Source: |
| Type: |
| Drug dosage vs efficacy, and actual dosage number of research papers. |
| 7201- | GGB, | Ginkgolide B Inhibits EMT and Promotes Pyroptosis in Gastric Cancer via AKT/mTOR Pathway |
| - | vitro+vivo, | GC, | AGS | - | in-vitro, | GC, | HGC27 |
| 7276- | GGB, | Pharmacokinetics of Ginkgolide B after Oral Administration of Three Different Ginkgolide B Formulations in Beagle Dogs |
| - | in-vivo, | Nor, | NA |
| 7140- | GI, | Benefits of Ginger and Its Constituent 6-Shogaol in Inhibiting Inflammatory Processes |
| - | Review, | Var, | NA |
| 7143- | GI, | Chemo, | Effect of a Standardized Ginger Root Powder Regimen on Chemotherapy-Induced Nausea and Vomiting: A Multicenter, Double-Blind, Placebo-Controlled Randomized Trial |
| - | Trial, | Var, | NA |
| - | Trial, | Var, | NA |
| - | Trial, | BC, | NA |
| 7136- | GI, | [6]-shogaol inhibits growth and induces apoptosis of non-small cell lung cancer cells by directly regulating Akt1/2 |
| - | vitro+vivo, | NSCLC, | H1650 |
| 7135- | GI, | Examination of the Pharmacokinetics of Active Ingredients of Ginger in Humans |
| - | Trial, | Nor, | NA |
| 7139- | GI, | 6-Shogaol Exhibits a Promoting Effect with Tax via Binding HSP60 in Non-Small-Cell Lung Cancer |
| - | vitro+vivo, | Lung, | A549 | - | in-vitro, | Melanoma, | A375 | - | in-vitro, | GBM, | U251 |
| 7138- | GI, | 6-Shogaol exerts anti-proliferative and pro-apoptotic effects through the modulation of STAT3 and MAPKs signaling pathways |
| - | vitro+vivo, | BC, | MDA-MB-231 | - | in-vitro, | Pca, | DU145 | - | in-vitro, | Liver, | HepG2 | - | in-vitro, | Lung, | A549 |
| 7152- | GI, | Role of Ginger in management of nausea among patients receiving chemotherapy |
| - | Trial, | Var, | NA |
| 7154- | GI, | Chemo, | Effects of Ginger Intake on Chemotherapy-Induced Nausea and Vomiting: A Systematic Review of Randomized Clinical Trials |
| - | Review, | Var, | NA |
| 7155- | GI, | BSB, | Effect of Ginger and Chamomile on Nausea and Vomiting Caused by Chemotherapy in Iranian Women with Breast Cancer |
| - | Trial, | BC, | NA |
| 2465- | GI, | Effect of daily ginger consumption on platelet aggregation |
| - | Trial, | Nor, | NA |
| 7245- | Gink, | Ginkgetin inhibits the growth of DU-145 prostate cancer cells through inhibition of signal transducer and activator of transcription 3 activity |
| - | vitro+vivo, | Pca, | DU145 | - | in-vitro, | CRC, | HCT116 | - | in-vitro, | Nor, | MCF10 |
| 7248- | Gink, | Studies on the cytotoxic mechanisms of ginkgetin in a human ovarian adenocarcinoma cell line |
| - | in-vitro, | Ovarian, | OVCAR-3 | - | in-vitro, | Cerv, | HeLa | - | NA, | NA, | OV1369 |
| 7250- | Gink, | Ginkgetin from Ginkgo biloba: mechanistic insights into anticancer efficacy |
| - | Review, | Var, | NA |
| - | in-vitro, | Lung, | A549 | - | in-vitro, | Lung, | H1299 |
| 7258- | Gink, | Ginkgetin inhibits the growth of DU−145 prostate cancer cells through inhibition of signal transducer and activator of transcription 3 activity |
| - | vitro+vivo, | Pca, | DU145 | - | in-vitro, | CRC, | HCT116 |
| 7267- | Gink, | Neuroprotective Potential of Biflavone Ginkgetin: A Review |
| - | Review, | AD, | NA | - | Review, | Park, | NA | - | Review, | Stroke, | NA |
| 7264- | Gink, | Anti-tumor effect of ginkgetin on human hepatocellular carcinoma cell lines by inducing cell cycle arrest and promoting cell apoptosis |
| - | vitro+vivo, | HCC, | HepG2 | - | NA, | HCC, | SK-HEP-1 |
| 7262- | Gink, | Ginkgetin suppresses ovarian cancer growth through inhibition of JAK2/STAT3 and MAPKs signaling pathways |
| - | in-vitro, | Ovarian, | A2780S | - | in-vitro, | Ovarian, | SKOV3 |
| 7302- | GlaB, | Glabrescione B delivery by self-assembling micelles efficiently inhibits tumor growth in preclinical models of Hedgehog-dependent medulloblastoma |
| - | vitro+vivo, | MB, | NA |
| 7305- | GoldNP, | Rad, | The use of gold nanoparticles to enhance radiotherapy in mice |
| - | in-vivo, | Var, | NA |
| 7304- | GoldNP, | Phase I and Pharmacokinetic Studies of CYT-6091, a Novel PEGylated Colloidal Gold-rhTNF Nanomedicine |
| - | Study, | Var, | NA |
| 7321- | Gos, | The potential roles of gossypol as anticancer agent: advances and future directions |
| - | Review, | Var, | NA |
| 7317- | Gos, | A phase II study of AT-101 (gossypol) in chemotherapy-sensitive recurrent extensive stage small cell lung cancer (ES-SCLC) |
| - | Trial, | Lung, | NA |
| 7316- | Gos, | PacT, | carbop, | Chemo, | A phase I study of AT-101, a BH3 mimetic, in combination with paclitaxel and carboplatin in solid tumors |
| - | Trial, | Var, | NA |
| 7311- | Gos, | Systematic Review of Gossypol/AT-101 in Cancer Clinical Trials |
| - | Review, | CLL, | NA |
| 7314- | Gos, | The BH3 mimetic (±) gossypol induces ROS-independent apoptosis and mitochondrial dysfunction in human A375 melanoma cells in vitro |
| - | in-vitro, | Melanoma, | A375 |
| 7337- | Gra, | Synergistic interactions among flavonoids and acetogenins in Graviola (Annona muricata) leaves confer protection against prostate cancer |
| - | in-vitro, | Pca, | NA |
| - | Trial, | Nor, | NA |
| 7324- | GSE, | A Pilot Study of a Grape Seed Procyanidin Extract for Lung Cancer Chemoprevention |
| - | Trial, | Lung, | NA |
| 7323- | GSE, | Grape seed procyanidin extract against lung cancer: the role of microrna-106b, bioavailability, and bioactivity |
| - | vitro+vivo, | Lung, | NA |
| 7322- | GSE, | MicroRNA-19a/b mediates grape seed procyanidin extract-induced anti-neoplastic effects against lung cancer |
| - | vitro+vivo, | Lung, | A549 | - | in-vitro, | Lung, | H520 | - | in-vitro, | Lung, | H1299 | - | in-vitro, | Nor, | BEAS-2B |
| 7329- | GSE, | Grape Seed Extract Positively Modulates Blood Pressure and Perceived Stress: A Randomized, Double-Blind, Placebo-Controlled Study in Healthy Volunteers |
| - | Trial, | Nor, | NA |
| 6561- | GSL, | Geraniol Pharmacokinetics, Bioavailability and Its Multiple Effects on the Liver Antioxidant and Xenobiotic-Metabolizing Enzymes |
| - | in-vivo, | Nor, | NA |
| 7134- | GSL, | Phase I study of oral spirogermanium |
| - | Trial, | Var, | NA |
| 4307- | H2, | Hydrogen Gas Attenuates Toxic Metabolites and Oxidative Stress-Mediated Signaling to Inhibit Neurodegeneration and Enhance Memory in Alzheimer’s Disease Models |
| - | in-vivo, | AD, | NA |
| 4308- | H2, | A biomimetic upconversion nanoreactors for near-infrared driven H2 release to inhibit tauopathy in Alzheimer's disease therapy |
| - | in-vivo, | AD, | NA |
| 7484- | H2, | Hydrogen Gas Attenuates Toxic Metabolites and Oxidative Stress-Mediated Signaling to Inhibit Neurodegeneration and Enhance Memory in Alzheimer's Disease Models |
| - | in-vivo, | AD, | NA |
| 7481- | H2, | Rad, | Clinical Efficacy of Hydrogen Therapy on Acute Radiation Enteritis and Inflammatory Response in Patients with Cervical Cancer Undergoing Concurrent Chemoradiation Therapy |
| - | Trial, | Var, | NA |
| 7482- | H2, | Molecular Hydrogen Therapy: Mechanisms, Delivery Methods, Preventive, and Therapeutic Application |
| - | Review, | Var, | NA | - | Review, | IBD, | NA | - | Review, | Stroke, | NA | - | Review, | Sepsis, | NA | - | Review, | AD, | NA |
| 7486- | H2, | Effects of hydrogen-rich water on blood uric acid in patients with hyperuricemia: A randomized placebo-controlled trial |
| - | Trial, | Nor, | NA |
| 7485- | H2, | Molecular hydrogen inhibits neuroinflammation and ameliorates depressive-like behaviors and short-term cognitive impairment in senescence-accelerated mouse prone 8 mice |
| - | in-vivo, | Nor, | NA |
| 7487- | H2, | A comprehensive review of molecular hydrogen as a novel nutrition therapy in relieving oxidative stress and diseases: Mechanisms and perspectives |
| - | Review, | Nor, | NA |
| 7489- | H2, | Molecular Hydrogen in the Treatment of Respiratory Diseases |
| - | Review, | Asthma, | NA |
| 7491- | H2, | Transdermal hydrogen therapy for psoriasis using cavity-embedded double-conical microneedles |
| - | in-vivo, | PSA, | NA |
| 7926- | H2, | Hydrogen gas inhalation enhances alveolar macrophage phagocytosis in an ovalbumin-induced asthma model |
| - | in-vivo, | Asthma, | NA |
| 7925- | H2, | Inhalation of hydrogen gas attenuates airway inflammation and oxidative stress in allergic asthmatic mice |
| - | in-vivo, | Asthma, | NA |
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:1114 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid